FDA approved two new drugs for the treatment of hepatitis C in children and adolescents. The drugs Sovaldi and Harvoni will be used to treat six major HCV strains in pediatric patients aged 12 years and above.
FDA approved two new drugs for the treatment of hepatitis C in children and adolescents. The drugs Sovaldi and Harvoni will be used to treat six major HCV strains in pediatric patients aged 12 years and above.
Share this Article
Recommended